Results 111 to 120 of about 1,587 (177)

A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma. [PDF]

Cancers (Basel), 2022
Dell'Anno I, Melani A, Martin SA, Barbarino M, Silvestri R, Cipollini M, Giordano A, Mutti L, Nicolini A, Luzzi L, Aiello R, Gemignani F, Landi S.   +12 more
europepmc   +1 more source

Estimate of cost of the Hospital Internments for Mesotelioma in Brazil

, 2013
No Brasil, o amianto é usado em larga escala há muitas décadas. O mesotelioma - câncer de pleura relacionado à inalação da poeira de amianto - só costuma manifestar-se cerca de 20 anos após o contato ocupacional e/ou ambiental.
Martins, Francisco Pedra, Chibante, Antonio Monteiro da Silva, Luna, Carolina de Almeida, Castro, Hermano Albuquerque de   +3 more
core  

Translation, Cultural Adaptation, and Content Validation of a Pleural Mesothelioma Questionnaire to Portuguese Context - A Key Tool for Epidemiological Surveillance. [PDF]

Port J Public Health
Santos C, Sacadura-Leite E, Feijó S, Dixe MDA, Astoul P, Sousa-Uva A.   +5 more
europepmc   +1 more source

Malignant Pleural Mesothelioma: Analysis of 70 Cases in the Last Decade. [PDF]

Open Respir Arch
Garcia-Prieto F, Pardo SC, Ramírez MTR, Fernández AA.   +3 more
europepmc   +1 more source

La reutilización de biomarcadores para otros fines: oportunidades y dificultades en el cambiante campo de la medicina de laboratorio. [PDF]

Adv Lab Med
Gruson D, Menghoun N, Pouleur AC, Bayes Genis A.   +3 more
europepmc   +1 more source

Evaluation of the Role of p53 Tumour Suppressor Posttranslational Modifications and TTC5 Cofactor in Lung Cancer. [PDF]

Int J Mol Sci, 2021
Alhebshi H, Tian K, Patnaik L, Taylor R, Bezecny P, Hall C, Muller PAJ, Safari N, Creamer DPM, Demonacos C, Mutti L, Bittar MN, Krstic-Demonacos M.   +12 more
europepmc   +1 more source

Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer. [PDF]

Mol Oncol
Rigon M, Mutti L, Campanella M.
europepmc   +1 more source

Malignant pleural mesothelioma: an update. [PDF]

J Bras Pneumol, 2021
Hajj GNM, Cavarson CH, Pinto CAL, Venturi G, Navarro JR, Lima VCC.   +5 more
europepmc   +1 more source

Use of low-dose immune checkpoint inhibitors in low- and middle-income countries: a national survey of oncologists and hematologists in Mexico. [PDF]

Ecancermedicalscience
Meraz-Brenez A, Soto-Perez-De-Celis E, Demichelis-Gomez R, Verduzco-Rodriguez L, Gupta A, Ragavan M, Chino F, Verduzco-Aguirre HC.   +7 more
europepmc   +1 more source

Comparison of mortality in patients on chemotherapy or immunotherapy during and before COVID-19 pandemic. Multicenter matched cohort study in Argentina. [PDF]

Rev Peru Med Exp Salud Publica, 2023
Itkin B, Straminsky S, Cáceres H, Onassis M, García AE, Avanzi L, Kaminszczik L, Serna Sejas R, Rapaccioli M, Billordo G, Lavaccara D, Lanzavecchia J, Gibbons L, Settecase E, Bardach A.   +14 more
europepmc   +1 more source